Oral Colchicine 0.5 mg tablet taken daily for median of 3 years. Eligible and consenting participants will be registered and then commenced on Run-In treatment consisting of 1 oral tablet (0.5mg of co Clinical Trials
2 recruitingIntervention
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
The effect of Colchicine on Cardiovascular Outcomes in Stroke Study (The CASPER Study)
AtherosclerosisIschemic StrokeTransient Ischemic Attack
University of Sydney1,500 enrolled9 locationsACTRN12621001408875
Recruiting
Phase 3
The effect of Colchicine on Cardiovascular Outcomes in Acute Coronary Syndrome Study (The COLCARDIO-ACS Study)
AtherosclerosisIschaemic heart disease
University of Sydney3,000 enrolled16 locationsACTRN12616000400460